Brief: Relay Therapeutics Q1 Net Income USD -73.291 Million Vs. IBES Estimate USD -65 Million
May 05 (Reuters) - Relay Therapeutics Q1 basic EPS USD -0.41. Q1 operating income USD -78.59 million Q1 operating expenses USD 81.59 million Q1 revenue USD 3 million vs. IBES estimate USD 2.56 million Q1 EPS USD -0.41
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock